Palmitic Acid
CAS 57-10-3
Palmitic Acid (CAS 57-10-3) is a pharmaceutical compound with 11 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | MIC | 601.3846153846154 ug.mL-1 | 26 | - |
| - | IC50 | 7880.154117647058 nM | 16 | - |
| - | IC50 | 19.6875 ug.mL-1 | 8 | - |
| - | Potency | 19477.149999999998 nM | 8 | - |
| - | MIC | 400000 nM | 4 | - |
| - | AC50 | 24840.15 nM | 2 | - |
| - | EC50 | 17504.9 nM | 2 | - |
| - | Kd | 41901 nM | 2 | - |
| - | Ki | 569 nM | 2 | - |
| - | MIC | 20 ug | 2 | - |
| - | EC50 | 38.3 ug.mL-1 | 1 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| FFA1 receptor FFAR1 |
Full agonist | 3.8 pEC50 | 12496284|12565875|12629551 |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| PALMITIC ACID | 1426390 | SU | MTHSPL |
| Palmitic Acid | 1426390 | SU | MTHSPL |
| palmitic acid | 1426390 | SU | MTHSPL |
| palmitic acid | 1426390 | PIN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Palmitic Acid used for in pharmaceutical contexts?
Palmitic Acid (CAS 57-10-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Palmitic Acid?
No adverse-event association or SIDER side-effect rows are rendered for Palmitic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Palmitic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Palmitic Acid with EU status "permitted".
What clinical phase is Palmitic Acid in?
No phase 1-4 clinical development badge is rendered for Palmitic Acid because the matched compound identifier rows do not contain a max-phase value.